VisionQuest Biomedical was founded in 2007 with the goal of developing and commercializing advanced technologies aimed at improving care in diabetes.
Through grant funding from the National Institutes of Health and private investment this stated strategic objective is being met, as evidenced in the commercialization of two NIH-funded technologies at clinics screening for diabetic retinopathy.
VisionQuest has developed and successfully deployed a software product for automatic analysis of retinal images in the detection of lesions in patients with diabetic retinopathy, age-related macular degeneration (AMD), and glaucoma.
Our automatic, real-time image quality screening system is also now being used in two commercial retinal cameras to ensure the highest possible retinal image quality, critically important for reading centers to make the best possible determination of a case.
VisionQuest Biomedical Milestones
EyeStar deployed in Mexico
Diabetic Foot testing device development.
Aspire clinical testing in Africa
+25,000 patients tested with Eyestar
Bring Eyestar to USA
VisionQuest's products saving visions and lives Worldwide
Our mission is to develop and deploy image-based technologies to improve access to health care for millions of individuals in the United States and around the world, especially in the fields of diabetes and eyecare.
CEO & Founder
Simon is an expert in AI and ophthalmology. He has worked in this field for over 18 years and has deep knowledge of the market.
Born and raised in Peru, Simon led the development of EyeStar and is now focused on its expansion worldwide.
CTO & Founder
Pete is the principal investigator on the NIH grants that funded the development of EyeStar. He continues his mission of developing AI technologies for health care and securing additional non-dilutive funding.
Sheila Nemeth COMT
Lead Retinal Grader
Sheila has over 30 years of experience in retinal image grading for multiple diseases such as diabetic retinopathy, macular degeneration, and malarial retinopathy.
Jeff Wigdahl PhD
Jeff specializes in developing software for retinal image analysis. He has developed software for detection of retinopathy of prematurity, diabetic retinopathy, and hypertensive retinopathy.
He obtained his Master’s degree from the University of New Mexico ad his PhD from the University of Padova.
Dean has over 25 years of accounting experience in various industries including Healthcare R&D, Oil and Gas, and Mining. He has extensive experience in Financial Reporting and Budgeting.
He obtained his Bachelor of Business Administration from The University of Texas at Arlington.
Sheraz has over 35 years of administrative experience. She handles the duties of clinical coordinator for the i-RxTherm project and provides administrative assistance to VisionQuest’s leadership.
Aswathy received her Master’s degree in Electrical Engineering from The University of New Mexico in 2017 and is currently pursuing her PhD.
Her research focuses on applying machine learning and image processing to real-world problems. At VisionQuest she develops deep learning techniques for Aspire.
Send us a message, we want to hear from you.